International Cannabis Weekly: 422

AUSTRALIAN MEDICAL ASSOCIATION SUBMITS RECOMMENDATIONS ON CANNABIS REGULATION REFORM

The peak professional body for doctors in Australia  — the Australian Medical Association (AMA) — has published its submission for the Therapeutic Goods Administration’s (TGA’s) review into unapproved medicinal cannabis products.

READ MORE  »

WHAT WILL ‘CZECH TRUMP’ MEAN FOR THE COUNTRY’S CANNABIS INDUSTRY?

READ MORE »

MEDICAL CANNABIS LEADS TO LARGE REDUCTIONS IN OPOID PRESCRIPTIONS

READ MORE »

• PhCANN outlines its disciplined growth vision for Europe’s pharmaceutical cannabis market.
• Europe is set to approve the first-ever multi-compound cannabis-based medicine.
• Solihull Health Check rebrands as Airmed Clinic through partnership with The VOR Group.
• Cannavigia highlights growing need for full compliance across Europe’s medical cannabis market.
• Researchers urge implementation of second pillar of the KCANG cannabis research framework.
• Terphogz launches as ECS Botanics expands its cannabis footprint into European markets. 

   

GET TICKETS NOW »

• Study has found blunt smoking has increased significantly among U.S. cannabis users.
• California governor has vetoed bill allowing direct cannabis deliveries to patients.
• Florida governor admits cannabis legalisation is popular despite his opposition.
• Nebraska Medical Cannabis Commission issues operational guidance ahead of launch.
• Goldflower Cannabis has opened its eleventh Florida dispensary in Cape Coral.
• Maine marks five years of adult-use sales with a detailed report on cannabis market data.
• Texas Original launches state’s first medical cannabis oral syringe for patients.
• Colorado has introduced affordable cannabis programme to support cancer patients.

• Inside Canada’s latest cannabis retail technology landscape and innovation report.
• Former Canadian cannabis cultivation site to be repurposed as an AI data centre.
• Taiwan News: Canadian cannabis industry developments and market connections explored.
• BC liquor and cannabis stores remain closed as strike action expands across province.
• Organigram launches Happly, its third hemp-derived THC brand targeting U.S. markets.
• Google expands its cannabis advertising pilot programme to government operators in Canada.

WATCH NOW »

• Brazil continues to struggle with defining clear regulations for medical cannabis cultivation.
• Tilray Medical enters joint venture to expand cannabis operations into Panama.
• São Paulo government invests R$16 million in new cannabis research and innovation centre.
• Anvisa has approved another cannabis-based medicinal product for Brazil’s market.

• Australian Medical Association submits recommendations to TGA on cannabis regulation reform.
• Leafio publishes comprehensive medicinal cannabis guide designed for Australian pharmacists.
• Pharmacrop unveils new product range after revamping former Tikun cultivation facility.
• Victoria rejects proposed cannabis reforms following two-year parliamentary inquiry.

• New technologies drive precision and compliance in South Africa’s medical cannabis market.
• Cilo Cybin announces main board listing on JSE to support cannabis expansion strategy.